跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambiceph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambiceph
Approved
STANDARD
Ambiceph
Gnana Life Sciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
48eecc3a72ed2c3b
Company
Gnana Life Sciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
48eecc3a72ed2c3b
Drug Approval Philippines Name
Ambiceph
Product Name
Ambiceph
Registration Number
DRP-4186
Brand Name
Ambiceph
Generic Name
Ceftriaxone (as Sodium)
Dosage Form
Powder for Injection (I.M./I/V/)
Dosage Strength
1 g
Manufacturer
Gnana Life Sciences Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Pharmalife Distribution
Issuance Date
26 October 2022
Expiry Date
28 January 2028
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
48eecc3a72ed2c3b
Type
Standard
Back to Philippines FDA Approvals